Why Life Sciences Manufacturing AI Keeps Failing at the Finish Line

by Kevin McMahon | posted on May 08, 2026

The data on AI pilots in manufacturing is not encouraging. Depending on who you ask, somewhere between 70% and 90% of AI and digitalization initiatives in manufacturing never make it to production. In my work across pharma, biotech, and cell and gene therapy manufacturing environments, I’ve watched this pattern repeat itself with remarkable consistency. The failure modes are almost always the same… and almost never about the AI itself.

This isn’t just an industry anecdote anymore. Gartner’s March 2026 Market Guide for Manufacturing Execution Systems makes the inflection point explicit: the conversation has moved from AI experimentation to AI execution. The focus now is on “AI delivery and trust, data privacy for AI, and agentic workflows.” The question is no longer whether to use AI in manufacturing. It’s whether your organization has built the infrastructure to make it real.

Most haven’t. And the gap between AI-ready and AI-actionable is where promising initiatives go up in smoke.

The Three Failure Modes I Keep Seeing

The first is data architecture, or the lack of one.

Pilot teams build impressive proofs-of-concept on curated datasets with throwaway architectures. A standalone model, disconnected from production systems, trained on clean data assembled specifically for the demo. Then they try to scale and hit a wall: siloed historians, inconsistent tag naming, missing metadata, and no integration layer between the AI solution and the MES, LIMS, ERP, or QMS systems it needs to operate in the real world. The model that worked beautifully in the demo environment can’t function in the production one because the data foundation was never built to support it.

AI can only be as effective as the data it is built and trained upon. That’s not a software problem. It’s an infrastructure problem. And most organizations try to solve it after the pilot, when it should have been solved before.

The second failure mode is organizational.

The pilot was run by a small, enthusiastic team with direct executive sponsorship. Scaling requires genuine buy-in from plant operations, quality, IT, regulatory, and maintenance, none of whom were in the room when the pilot was designed. By the time those stakeholders are brought in, they’re being asked to absorb someone else’s solution into their workflows. That’s a very different conversation than being part of building it.

The third is change management, which is usually absent entirely.

Most pilot plans have a detailed technical architecture and no plan at all for how operators, supervisors, and quality teams will actually use the tool in daily work. Technology adoption in regulated manufacturing environments doesn’t happen because a system is available. It happens because the system is integrated into the workflow, the team understands why it’s there, and the guardrails are in place to keep it compliant.

What Gartner Is Actually Telling Us

The Gartner MES Market Guide finding that stands out to me isn’t about any specific capability. It’s about accountability. Gartner notes that only a fraction of MES vendors can point to live, production AI use cases today. That’s a significant gap between what gets announced and what gets deployed.

The report’s framing, AI delivery and trust, data privacy, and agentic workflows, reflects where the industry’s center of gravity is moving. Agentic AI isn’t theoretical in life sciences manufacturing anymore. It’s the direction. Autonomous agents that can query data, surface insights, trigger workflows, and take governed action across the production environment represent a meaningful shift in what manufacturing intelligence can do. But agents without grounding are just generating outputs into a vacuum. Without access to structured, contextualized, governed data, they can’t operate safely or usefully in a regulated environment. There must be a human in the loop who is accountable for decisions made on a regulated product production; “the AI said so” is not a valid reason to dispense culpability.

This is why the MES category is evolving the way it is. Cloud is table stakes. AI is moving toward accountability. And differentiation is shifting to depth: depth of data, domain expertise, and real-world execution.

The Infrastructure Question Most Organizations Are Still Getting Wrong

The companies that successfully move from AI pilot to production share a few things in common. They start with the business problem, not the technology. They invest in data infrastructure before they build and deploy solutions. And they treat adoption as part of the design, not a Phase 2 consideration.

What that looks like in practice is a unified data environment where manufacturing, quality, and research data aren’t siloed, where batch records, equipment status, sample tracking, and compliance data exist in a structured, connected model that AI can actually reason over. Where integration isn’t an afterthought bolted on after deployment, but a core architectural principle. And where the AI layer is grounded in governed, organizational context (with approved documentation, existing permissions, and live execution data) rather than operating on general knowledge disconnected from your actual processes.

This is the gap that a digital unified platform addresses. Not just connecting systems, but creating the conditions under which AI can operate with awareness, constraints, and full traceability, which are exactly the conditions a regulated manufacturing environment demands.

Where L7|ESP® and L7|SYNAPSE™ Come In

L7|ESP was designed around this problem. As an enterprise science platform that unifies LIMS, MES, ELN, scheduling, and quality functions in a single connected environment, it provides the structured data foundation that AI initiatives require before they can scale. The L7 Knowledge Graph makes the relationships between data points across manufacturing processes visible and traversable. L7|INTELLIGENCE® turns that structured data into operational insight, identifying trends, dependencies, and potential bottlenecks in ways that disconnected point solutions simply cannot or struggle to connect across different architectures.

L7|SYNAPSE, the agentic AI layer of L7|ESP, takes this further. It’s built on the premise that agents without context are just guessing. L7|SYNAPSE grounds AI in governed platform data, approved documentation, and live execution context, so it can ask, retrieve, execute, and trace with full organizational awareness, allowing informed decisions at critical junctures in the process. That’s not a general-purpose AI capability grafted onto a platform. It’s an agentic layer built to operate within the specific constraints and requirements of life sciences manufacturing.

The Gartner framing, AI delivery and trust, maps directly to what a grounded, governed agentic layer enables. Trust doesn’t come from the model. It comes from the infrastructure around the model.

The Shift That’s Already Underway

Manufacturing AI in life sciences is not going to stay in the pilot phase. The organizations investing in the right infrastructure now will be the ones executing at scale in two to three years. The ones continuing to build standalone proofs-of-concept on curated data will still be asking why their pilots aren’t making it to production.

The path from AI-ready to AI-actionable runs through data architecture, organizational alignment, and a platform built to support governed intelligent execution. Those aren’t technology problems in isolation. But technology that was designed from the ground up to solve them makes the difference between another failed pilot and a manufacturing operation that’s genuinely running on AI.